Targeting the glucocorticoid receptor in breast and prostate cancers

Molecular portraits of human breast tumours

Perou, C., Sørlie, T., Eisen, M., van de Rijn, M., Jeffrey, S., Rees, C. A., Pollack, J., Ross, D., Johnsen, H., Akslen, L., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,551 · see citing works

Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer

Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,239 · see citing works

Ki67 expression in breast cancer

Elkablawy, M. A., Albasri, A. M., Mohammed, R. A., Hussainy, A. S., Nouh, M. M., & Alhujaily, A. S. (2016) · Saudi Medical Journal · doi:10.15537/smj.2016.2.12285 · Cited by 4,382 · see citing works

Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

Ryan, C. J., Smith, M. R., de Bono, J. S., Molina, A., Logothetis, C. J., de Souza, P., Fizazi, K., Mainwaring, P., Piulats, J. M., Ng, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209096 · Cited by 2,796 · see citing works

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

Tannock, I. F., Osoba, D., Stockler, M. R., Ernst, D. S., Neville, A. J., Moore, M. J., Armitage, G. R., Wilson, J. J., Venner, P. M., Coppin, C., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.6.1756 · Cited by 1,575 · see citing works

Biology of Progressive, Castration-Resistant Prostate Cancer: Directed Therapies Targeting the Androgen-Receptor Signaling Axis

Scher, H. I., & Sawyers, C. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.4777 · Cited by 1,025 · see citing works

Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade

Arora, V. K., Schenkein, E., Murali, R., Subudhi, S. K., Wongvipat, J., Balbas, M., Shah, N., Cai, L., Efstathiou, E., Logothetis, C., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.012 · Cited by 985 · see citing works

Triple-negative breast cancer—current status and future directions

Gluz, O., Liedtke, C., Gottschalk, N., Pusztai, L., Nitz, U. A., & Harbeck, N. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp492 · Cited by 688 · see citing works

Androgen receptor signaling in prostate cancer development and progression

Tindall, D. J., & Lonergan, P. E. (2011) · Journal of Carcinogenesis · doi:10.4103/1477-3163.83937 · Cited by 544 · see citing works

Structural basis of androgen receptor binding to selective androgen response elements

Shaffer, P. L., Jivan, A., Dollins, D. E., Claessens, F., & Gewirth, D. T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401123101 · Cited by 400 · see citing works

Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes.

Korach, K. S., Couse, J. F., Curtis, S. W., Washburn, T. F., Lindzey, J. K., Kimbro, K. S., Eddy, E. M., Migliaccio, S., Snedeker, S. M., Lubahn, D. B., et al. (1996) · PubMed · Cited by 370 · see citing works

Tumor clone dynamics in lethal prostate cancer

Carreira, S., Romanel, A., GOODALL, J. C., Grist, E., Ferraldeschi, R., Miranda, S., Prandi, D., Lorente, D., Frenel, J., Pezaro, C. J., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009448 · Cited by 337 · see citing works

Activation of the Glucocorticoid Receptor Is Associated with Poor Prognosis in Estrogen Receptor-Negative Breast Cancer

Pan, D., Kocherginsky, M., & Conzen, S. D. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0362 · Cited by 298 · see citing works

Glucocorticoid Receptor Activity Contributes to Resistance to Androgen-Targeted Therapy in Prostate Cancer

Isikbay, M., Otto, K. B., Kregel, S., Kach, J., Cai, Y., Griend, D. J. V., Conzen, S. D., & Szmulewitz, R. Z. (2014) · Hormones and Cancer · doi:10.1007/s12672-014-0173-2 · Cited by 273 · see citing works

Progesterone and Glucocorticoid Receptors Recruit Distinct Coactivator Complexes and Promote Distinct Patterns of Local Chromatin Modification

Li, X., Wong, J., Tsai, S. Y., Tsai, M., & O’Malley, B. W. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.11.3763-3773.2003 · Cited by 245 · see citing works

FoxA1 Specifies Unique Androgen and Glucocorticoid Receptor Binding Events in Prostate Cancer Cells

Sahu, B., Laakso, M., Pihlajamaa, P., Ovaska, K., Sinielnikov, I., Hautaniemi, S., & Jänne, O. A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2350 · Cited by 230 · see citing works

Post-Translational Modifications of Nuclear Receptors and Human Disease

Anbalagan, M., Huderson, B. P., Murphy, L. C., & Rowan, B. G. (2012) · Nuclear Receptor Signaling · doi:10.1621/nrs.10001 · Cited by 212 · see citing works

Glucocorticoid Receptor Antagonism as a Novel Therapy for Triple-Negative Breast Cancer

Skor, M. N., Wonder, E. L., Kocherginsky, M., Goyal, A., Hall, B. A., Cai, Y., & Conzen, S. D. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3826 · Cited by 202 · see citing works

Estrogen receptor: A prognostic factor in breast cancer

Samaan, N. A., Buzdar, A. U., Aldinger, K. A., Schultz, P. N., Yang, K.-P., Romsdahl, M. M., & Martin, R. G. (1981) · Cancer · doi:10.1002/1097-0142(19810201)47:3 · Cited by 189 · see citing works

Interaction of Glucocorticoid Receptor (GR) with Estrogen Receptor (ER) α and Activator Protein 1 (AP1) in Dexamethasone-mediated Interference of ERα Activity

Karmakar, S., Jin, Y., & Nagaich, A. K. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.473819 · Cited by 137 · see citing works

Tumor suppressor activity of glucocorticoid receptor in the prostate

Yemelyanov, A. Y., Czwornog, J. L., Chebotaev, D. V., Karseladze, A. I., Kulevich, E. E., Yang, X. J., & Budunova, I. V. (2006) · Oncogene · doi:10.1038/sj.onc.1209991 · Cited by 130 · see citing works

Reprogramming the Chromatin Landscape: Interplay of the Estrogen and Glucocorticoid Receptors at the Genomic Level

Miranda, T. B., Voss, T. C., Sung, M.-H., Baek, S., John, S., Hawkins, M., Grøntved, L., Schiltz, R. L., & Hager, G. L. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0742 · Cited by 130 · see citing works

Low doses of oral dexamethasone for hormone-refractory prostate carcinoma

Nishimura, K., Nonomura, N., Yasunaga, Y., Takaha, N., Inoue, H., SUGAO, H., Yamaguchi, S., Ukimura, O., Miki, T., & Okuyama, Ä. (2000) · Cancer · doi:10.1002/1097-0142(20001215)89:12 · Cited by 125 · see citing works

Dexamethasone decreases xenograft response to paclitaxel through inhibition of tumor cell apoptosis

Pang, D., & Kocherginsky, M. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.8.2875 · Cited by 115 · see citing works

Modulation of Steroid Hormone Receptor Activity

Stanišić, V., Lonard, D. M., & O’Malley, B. W. (2010) · Progress in brain research · doi:10.1016/s0079-6123(08)81009-6 · Cited by 102 · see citing works

The expression of glucocorticoid receptor is negatively regulated by active androgen receptor signaling in prostate tumors

Xie, N., Cheng, H., Lin, D., Liu, L., Ou, Y., Li, J., Fazli, L., Gleave, M. E., Wang, Y. Z., Rennie, P. S., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29147 · Cited by 101 · see citing works

Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy

Keith, B. D. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-84 · Cited by 100 · see citing works

A Randomized Trial of Adjuvant Combination Chemotherapy With Or Without Prednisone in Premenopausal Breast Cancer Patients With Metastases in One to Three Axillary Lymph Nodes

Goldhirsch, A., Stjemsward, J., Hartmann, W., Davis, B., Zava, D. T., Jordan, V. C., Zimmermann, A., Baggenstoss, A. H., Wiedmer, C., Ramminger, C., et al. (1985) · Cancer Research · Cited by 97 · see citing works

Androgen and glucocorticoid receptors in the stroma and epithelium of prostatic hyperplasia and carcinoma.

Mohler, J. L., Chen, Y., Hamil, K. G., Hall, S. H., Cidlowski, J. A., Wilson, E. M., French, F. S., & Sar, M. (1996) · PubMed · Cited by 81 · see citing works

Serum/glucocorticoid‐regulated kinase 1 expression in primary human prostate cancers

Szmulewitz, R. Z., Chung, E. K., Al‐Ahmadie, H. A., Daniel, S., Kocherginsky, M., Razmaria, A. A., Zagaja, G. P., Brendler, C. B., Stadler, W. M., & Conzen, S. D. (2011) · The Prostate · doi:10.1002/pros.21416 · Cited by 72 · see citing works

Glucocorticoids and treatment of prostate cancer: a preclinical and clinical review

Fakih, M., Johnson, C. S., & Trump, D. L. (2002) · Urology · doi:10.1016/s0090-4295(02)01741-7 · Cited by 65 · see citing works

Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells

Courtin, A., Communal, L., Vilasco, M., Cimino, D., Mourra, N., Bortoli, M. D., Taverna, D., Faussat, A., Chaouat, M., Forgez, P., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1394-5 · Cited by 60 · see citing works

Coactivators enable glucocorticoid receptor recruitment to fine-tune estrogen receptor transcriptional responses

Bolt, M. J., Stossi, F., Newberg, J. Y., Orjalo, A. V., Johansson, H. E., & Mancini, M. A. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt100 · Cited by 57 · see citing works

New targets in triple-negative breast cancer

Copeland, R., & KANAAN, Y. M. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00415-4 · Cited by 57 · see citing works

Quantitative characterization of androgen receptor protein expression and cellular localization in circulating tumor cells from patients with metastatic castration-resistant prostate cancer

Reyes, E. E., VanderWeele, D. J., Isikbay, M., Duggan, R., Campanile, A., Stadler, W. M., Griend, D. J. V., & Szmulewitz, R. Z. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0313-z · Cited by 41 · see citing works

New targets for triple-negative breast cancer.

Herold, C. I., & Anders, C. K. (2013) · PubMed · Cited by 34 · see citing works

A randomized trial of adjuvant combination chemotherapy with or without prednisone in premenopausal breast cancer patients with metastases in one to three axillary lymph nodes.

(1985) · PubMed · Cited by 24 · see citing works

Current therapy and drug resistance in metastatic castration-resistant prostate cancer

Cai, M., Song, X., Li, X., Chen, M., Guo, J., Yang, D., Chen, Z., & Zhao, S. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.100962 · Cited by 269 · see citing works

Critical Functions of the Lysosome in Cancer Biology

Davidson, S. M., & Heiden, M. G. V. (2016) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103101 · Cited by 209 · see citing works

Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancerPreprint

Siersbæk, R., Kumar, S. S., & Carroll, J. S. (2018) · Genes & Development · doi:10.1101/gad.316646.118 · Cited by 153 · see citing works

Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer

Li, J., Alyamani, M., Zhang, A., Chang, K., Berk, M. P., Li, Z., Zhu, Z., Petro, M., Magi‐Galluzzi, C., Taplin, M., et al. (2017) · eLife · doi:10.7554/elife.20183 · Cited by 122 · see citing works

Androgen receptor signaling pathways as a target for breast cancer treatment

Pietri, E., Conteduca, V., Andreis, D., Massa, I., Melegari, E., Sarti, S., Cecconetto, L., Schirone, A., Bravaccini, S., Serra, P., et al. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0190 · Cited by 97 · see citing works

Biological Actions of the Hsp90-binding Immunophilins FKBP51 and FKBP52

Zgajnar, N. R., Leo, S. A. D., Lotufo, C. M., Erlejman, A. G., Piwien‐Pilipuk, G., & Galigniana, M. D. (2019) · Biomolecules · doi:10.3390/biom9020052 · Cited by 94 · see citing works

Stress reduction strategies in breast cancer: Review of pharmacologic and non-pharmacologic based strategies

Gosain, R., Gage-Bouchard, E., Ambrosone, C., Repasky, E., & Gandhi, S. (2020) · Seminars in Immunopathology · doi:10.1007/s00281-020-00815-y · Cited by 85 · see citing works

Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy

Wilkinson, S. C., Ye, H., Karzai, F. H., Harmon, S. A., Terrigino, N. T., VanderWeele, D. J., Bright, J. R., Atway, R., Trostel, S. Y., Carrabba, N. V., et al. (2021) · European Urology · doi:10.1016/j.eururo.2021.03.009 · Cited by 79 · see citing works

Enzalutamide therapy for advanced prostate cancer: efficacy, resistance and beyond

Linder, S., van der Poel, H. G., Bergman, A. M., Zwart, W. T., & Preković, S. (2018) · Endocrine Related Cancer · doi:10.1530/erc-18-0289 · Cited by 74 · see citing works

Glucocorticoid Receptor:MegaTrans Switching Mediates the Repression of an ERα-Regulated Transcriptional Program

Yang, F., Ma, Q., Liu, Z., Li, W., Tan, Y., Jin, C., Ma, W., Hu, Y., Shen, J., Ohgi, K. A., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.03.019 · Cited by 67 · see citing works

Glucocorticoid receptors are required effectors of TGFβ1-induced p38 MAPK signaling to advanced cancer phenotypes in triple-negative breast cancer

Kerkvliet, C. J. P., Dwyer, A. R., Diep, C. H., Oakley, R. H., Liddle, C., Cidlowski, J. A., & Lange, C. A. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01277-8 · Cited by 65 · see citing works

SGK1 signaling promotes glucose metabolism and survival in extracellular matrix detached cells

Mason, J. A., Cockfield, J. A., Pape, D. J., Meissner, H., Sokolowski, M. T., White, T. C., Valentín López, J. C., Liu, J., Liu, X., Martínez-Reyes, I., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108821 · Cited by 64 · see citing works

Biobehavioral Pathways and Cancer Progression: Insights for Improving Well-Being and Cancer Outcomes

Chang, A., Sloan, E. K., Antoni, M. H., Knight, J. M., Telles, R., & Lutgendorf, S. K. (2022) · Integrative Cancer Therapies · doi:10.1177/15347354221096081 · Cited by 59 · see citing works

Genome-wide crosstalk between steroid receptors in breast and prostate cancers

Paakinaho, V., & Palvimo, J. J. (2021) · Endocrine Related Cancer · doi:10.1530/erc-21-0038 · Cited by 55 · see citing works

Role of pyroptosis in cancer and its therapeutic regulation

Mamun, A. A., Mimi, A. A., Aziz, M. A., Zaeem, M., Ahmed, T., Munir, F., & Xiao, J. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174444 · Cited by 53 · see citing works

Phase I/II Trial of Enzalutamide and Mifepristone, a Glucocorticoid Receptor Antagonist, for Metastatic Castration-Resistant Prostate Cancer

Serritella, A. V., Shevrin, D., Heath, E. I., Wade, J. L., Martinez, E., Anderson, A. K. L., Schonhoft, J., Chu, Y.-L., Karrison, T., Stadler, W. M., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-4049 · Cited by 53 · see citing works

Selective glucocorticoid receptor modulators (SGRMs) delay castrate-resistant prostate cancer growth

Kach, J., Long, T., Selman, P., Tonsing-Carter, E., Bacalao, M. A., Lastra, R., de Wet, L., Comiskey, S., Gillard, M., VanOpstall, C., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0923 · Cited by 48 · see citing works

Steroid metabolism in breast cancer: Where are we and what are we missing?

Africander, D., & Storbeck, K. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.05.016 · Cited by 39 · see citing works

Contribution of Immune Cells to Glucocorticoid Receptor Expression in Breast Cancer

Gandhi, S., Elkhanany, A., Oshi, M., Dai, T., Opyrchal, M., Mohammadpour, H., Repasky, E., & Takabe, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134635 · Cited by 39 · see citing works

Prognostic Significance of Glucocorticoid Receptor Expression in Cancer: A Systematic Review and Meta-Analysis

Bakour, N., Moriarty, F., Moore, G., Robson, T., & Annett, S. (2021) · Cancers · doi:10.3390/cancers13071649 · Cited by 38 · see citing works

Nuclear receptor profiling in prostatospheroids and castration-resistant prostate cancer

Wang, Z., Wu, D., Ng, C., Teoh, J. Y., Yu, S., Wang, Y., & Chan, F. L. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0280 · Cited by 33 · see citing works

Steroid Hormone Receptor Positive Breast Cancer Patient-Derived Xenografts

Matthews, S. B., & Sartorius, C. A. (2016) · Hormones and Cancer · doi:10.1007/s12672-016-0275-0 · Cited by 31 · see citing works

Hexose-6-phosphate dehydrogenase blockade reverses prostate cancer drug resistance in xenograft models by glucocorticoid inactivation

Li, J., Berk, M. P., Alyamani, M., Sabharwal, N., Goins, C. M., Alvarado, J., Baratchian, M., Zhu, Z., Stauffer, S. R., Klein, E. A., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abe8226 · Cited by 29 · see citing works

Selective glucocorticoid receptor-activating adjuvant therapy in cancer treatments

Sundahl, N., Clarisse, D., Bracke, M., Offner, F. C., Berghe, W. V., & Beck, I. M. E. (2016) · Oncoscience · doi:10.18632/oncoscience.315 · Cited by 29 · see citing works

A Brief Overview of the Paradoxical Role of Glucocorticoids in Breast Cancer

Михайловна, Ж. Е., Lylova, E. S., Savinkova, A. V., Александрович, М. С., Игоревич, К. К., Belitsky, G. A., Геннадиевна, Я. М., & Lesovaya, E. A. (2020) · Breast Cancer Basic and Clinical Research · doi:10.1177/1178223420974667 · Cited by 29 · see citing works

CUE domain‐containing protein 2 promotes the Warburg effect and tumorigenesis

Zhong, X., Tian, S., Zhang, X., Diao, X., Dong, F., Yang, J., Li, Z., Sun, L., Wang, L., He, X., et al. (2017) · EMBO Reports · doi:10.15252/embr.201643617 · Cited by 26 · see citing works

New Opportunities for Targeting the Androgen Receptor in Prostate CancerPreprint

Centenera, M. M., Selth, L. A., Ebrahimie, E., Butler, L. M., & Tilley, W. D. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a030478 · Cited by 26 · see citing works

Intestinal epithelial glucocorticoid receptor promotes chronic inflammation–associated colorectal cancer

Tang, S., Zhang, Z., Oakley, R. H., Li, W., He, W., Xu, X., Ji, M. H., Xu, Q., Chen, L., Wellman, A. S., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.151815 · Cited by 25 · see citing works

Targeting steroid hormone receptors for anti‐cancer therapy—A review on small molecules and nanotherapeutic approaches

Mahadik, N. S., Bhattacharya, D., Padmanabhan, A., Sakhare, K. R., Narayan, K. P., & Banerjee‬‬‬‬‬‬‬‬‬, R. (2021) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1755 · Cited by 26 · see citing works

Expression of glucocorticoid receptor is associated with aggressive primary endometrial cancer and increases from primary to metastatic lesions

Tangen, I. L., Veneris, J. T., Halle, M. K., Werner, H. M. J., Trovik, J., Akslen, L. A., Salvesen, H. B., Conzen, S. D., Fleming, G. F., & Krakstad, C. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.09.013 · Cited by 24 · see citing works

Family Matters: Collaboration and Conflict Among the Steroid Receptors Raises a Need for Group Therapy

Sikora, M. J. (2016) · Endocrinology · doi:10.1210/en.2016-1778 · Cited by 21 · see citing works

Hormone-Targeted Therapy and Resistance

Metcalfe, C., Friedman, L. S., & Hager, J. H. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050512 · Cited by 21 · see citing works

Advances in the Current Understanding of the Mechanisms Governing the Acquisition of Castration-Resistant Prostate Cancer

Mao, Y., Yang, G., Li, Y., Liang, G., Xu, W., & Hu, M. (2022) · Cancers · doi:10.3390/cancers14153744 · Cited by 20 · see citing works

Comparative analysis of ginsenosides in human glucocorticoid receptor binding, transactivation, and transrepression

Hu, C. X., Lau, A. J., Wang, R., & Chang, T. K. H. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.10.019 · Cited by 19 · see citing works

Glucocorticoid receptor upregulation increases radioresistance and triggers androgen independence of prostate cancer

Chen, X., Chen, F., Ren, Y. T., Weng, G., Keng, P. C., Chen, Y., & Lee, S. O. (2019) · The Prostate · doi:10.1002/pros.23861 · Cited by 17 · see citing works

Perturbing local steroidogenesis to improve breast cancer immunity

Zhao, Q., Pramanik, J., Lu, Y., Homer, N. Z. M., Imianowski, C. J., Zhang, B., Iqbal, M., Shaji, S. K., Morris, A. C., Roychoudhuri, R., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59356-3 · Cited by 15 · see citing works

Differentially Expressed Genes and Molecular Pathways in an Autochthonous Mouse Prostate Cancer Model

Verma, S., Shukla, S., Pandey, M., MacLennan, G. T., & Gupta, S. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00235 · Cited by 13 · see citing works

The Effect of Vinyasa Yoga Practice on the Well-Being of Breast-Cancer Patients during COVID-19 Pandemic

Zok, A., Matecka, M., Zapala, J., Izycki, D., & Baum, E. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20043770 · Cited by 12 · see citing works

Measuring glucocorticoid receptor expressionin vivowith PET

Truillet, C., Parker, M. F. L., Huynh, L. T., Wei, J., Jami, K. M., Wang, Y.-H., Shen, Y. S., Sriram, R., Wilson, D. M., Kurhanewicz, J. V., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24911 · Cited by 12 · see citing works

Reciprocal and Autonomous Glucocorticoid and Androgen Receptor Activation in Salivary Duct Carcinoma

Mitani, Y., Lin, S.-H., Pytynia, K. B., Ferrarotto, R., & El‐Naggar, A. K. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1603 · Cited by 12 · see citing works

Descriptive characteristics of prostate cancer in patients with a history of primary male breast cancer – a SEER analysis

Abhyankar, N., Hoskins, K. F., Abern, M. R., & Calip, G. S. (2017) · BMC Cancer · doi:10.1186/s12885-017-3640-7 · Cited by 10 · see citing works

Recent advances in understanding glucocorticoid receptor function in cancer.

Conzen, S. D. (2017) · PubMed · Cited by 10 · see citing works

Whence CRIPTO: The Reemergence of an Oncofetal Factor in ‘Wounds’ That Fail to Heal

Freeman, D. W., Sousa, E. R., Karkampouna, S., Zoni, E., Gray, P. C., Salomon, D. S., Julio, M. K., & Spike, B. T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810164 · Cited by 9 · see citing works

The KDM5 inhibitor PBIT reduces proliferation of castration-resistant prostate cancer cells via cell cycle arrest and the induction of senescence

Smith, T. M., White, T., Chen, Z., & Stewart, L. V. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.113991 · Cited by 8 · see citing works

Endolysosomal transient receptor potential mucolipins and two-pore channels: implications for cancer immunity

Ouologuem, L., & Bartel, K. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1389194 · Cited by 8 · see citing works

Molecular profiling of ex vivo prostate cancer CAF models captures stromal heterogeneity and drug vulnerabilities

Rantanen, F., Murumägi, A., Arjama, M., Välimäki, K. E., Multamäki, E., Mirtti, T. K., Rannikko, A. S., Pellinen, T. S., Ungureanu, D., & Kallioniemi, O. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02792-3 · Cited by 8 · see citing works

Crosstalk between Depression and Breast Cancer via Hepatic Epoxide Metabolism: A Central Comorbidity Mechanism

Ye, Z., Ganesan, K., Wu, M., Hu, Y., She, Y., Tian, Q., Ye, Q., & Chen, J. (2022) · Molecules · doi:10.3390/molecules27217269 · Cited by 8 · see citing works

Association of lifestyle and demographic factors with estrogenic and glucocorticogenic activity in Mexican American women

Fejerman, L., Sanchez, S. S., Thomas, R., Tachachartvanich, P., Riby, J. E., Gomez, S. L., John, E. M., & Smith, M. T. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw074 · Cited by 8 · see citing works

Evaluation of glucocorticoid-related genes reveals GPD1 as a therapeutic target and regulator of sphingosine 1-phosphate metabolism in CRPC

Liu, R., Zou, Z., Zhang, Z., He, H., Xi, M., Liang, Y., Ye, J., Dai, Q.-S., Wu, Y., Tan, H., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217286 · Cited by 7 · see citing works

Association between Environmental Temperature and Survival in Gastroesophageal Cancers: A Population Based Study

Gupta, K., George, A. M., Attwood, K. M., Gupta, A. K., Roy, A. M., Gandhi, S., Siromoni, B., Singh, A. K., Repasky, E. A., & Mukherjee, S. (2023) · Cancers · doi:10.3390/cancers16010074 · Cited by 6 · see citing works

Glucocorticoid receptor: a harmonizer of cellular plasticity in breast cancer—directs the road towards therapy resistance, metastatic progression and recurrence

Thakur, D., Sengupta, D., Mahapatra, E., Das, S., Sarkar, R., & Mukherjee, S. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10163-6 · Cited by 5 · see citing works

A TBX2-driven signaling switch from androgen receptor to glucocorticoid receptor confers therapeutic resistance in prostate cancer

Dutta, S., Khedmatgozar, H., Patel, G. K., Latour, D., Welsh, J., Mustafi, M., Mitrofanova, A., Tripathi, M., & Nandana, S. (2024) · Oncogene · doi:10.1038/s41388-024-03252-5 · Cited by 5 · see citing works

A Novel Radioligand Reveals Tissue Specific Pharmacological Modulation of Glucocorticoid Receptor Expression with Positron Emission Tomography

Huang, Y., Zhao, N., Wang, Y.-H., Truillet, C., Wei, J., Blecha, J. E., VanBrocklin, H. F., Seo, Y., Sayeed, M., Feldman, B. J., et al. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.9b01043 · Cited by 5 · see citing works

Steroid hormone receptors, exome sequencing and treatment responsiveness of breast cancer patient-derived xenografts originated in a South American country

Pataccini, G., Elia, A. M., Sequeira, G. R., Ambrosio, L., Coianis, M. I., Lamb, C. A., Rojas, P. A., Vázquez, P. M., Burruchaga, J., Spengler, E., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-86389-x · Cited by 4 · see citing works

Androgen receptor expression in triple negative breast cancer and its relationship to prognostic factors

Kneubil, M. C., Godoy, A. E. G., Coelho, G. P., Grochot, R. M., Rombaldi, R. L., Pasqualotto, F. F., Raimann, B. W., Madi, J. M., Reiriz, A. B., Alessi, M., et al. (2017) · Revista Brasileira de Mastologia · doi:10.5327/z2594539420170000205 · Cited by 4 · see citing works

Role of the Hsp90-Immunophilin Heterocomplex in Cancer Biology

Leo, S. A. D., Zgajnar, N. R., Mazaira, G. I., Erlejman, A. G., & Galigniana, M. D. (2019) · Current Cancer Therapy Reviews · doi:10.2174/1573394715666190102120801 · Cited by 4 · see citing works

Ras-ling with new therapeutic targets for metastasis

Mason, J. A., & Schafer, Z. T. (2017) · Small GTPases · doi:10.1080/21541248.2017.1310650 · Cited by 4 · see citing works

Advanced Triple-Negative Breast Cancer: Emerging Therapies and a Changing Treatment Landscape

Hennessy, M. A., Terman, E., Idossa, D. W., LeVee, A. A., Leon-Ferre, R. A., McArthur, H. L., & Nanda, R. (2026) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk-26-520506 · Cited by 3 · see citing works

Evidence for shared genetic risk factors between lymphangioleiomyomatosis and pulmonary function

Farré, X., Espín, R., Baiges, A., Blommaert, E., Kim, W., Giannikou, K., Herranz, C., Román, A., Sáez, B., Casanova, Á., et al. (2021) · ERJ Open Research · doi:10.1183/23120541.00375-2021 · Cited by 3 · see citing works

High glucocorticoid receptor expression in the sarcomatous versus carcinomatous elements of Mullerian carcinosarcomas

Kurnit, K. C., Steiner, M., Lastra, R. R., Weroha, S. J., Cursio, J., Lengyel, E. R., Fleming, G. F., & Conzen, S. D. (2022) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2022.100987 · Cited by 3 · see citing works

Expression and clinicopathological significance of glucocorticoid receptor, SGK1, and NDRG1 in hormone-naïve prostate carcinoma

Hata, S., Shimada, H., Sato, N., Koshiishi, M., Ise, K., Ogata, T., Yamashita, S., Ito, A., Sasano, H., & Nakamura, Y. (2022) · Medical Molecular Morphology · doi:10.1007/s00795-022-00332-x · Cited by 2 · see citing works

In Vivo Profiling with 18F-YJH08 Reveals Diverse Tissue Patterns of Antagonist/Glucocorticoid Receptor Interactions

Kim, H., Huang, Y., Zhao, N., Wang, Y.-H., Sakhamuri, S., Chopra, S., Hooshdaran, N., Sriram, R., Aggarwal, R. R., & Evans, M. J. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00833 · Cited by 2 · see citing works

Chronic psychosocial stress: a role in breast cancer etiology?

Fosse, R., & Behr, C. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1790548 · Cited by 1 · see citing works

Unmasking Upstream Gene Expression Regulators with miRNA-corrected mRNA Data

Bollmann, S. R., Bu, D., Wang, J., & Bionaz, M. (2015) · Bioinformatics and Biology Insights · doi:10.4137/bbi.s29332 · Cited by 1 · see citing works

In vitro screening of effectiveness and antiproliferative effects of potential ddit4 inhibitors for breast cancer cell lines

Михайловна, Ж. Е., Grigoreva, D. D., Lylova, E. S., Павловна, М. В., Sagitova, G. R., Khayrieva, G., Trapeznikova, E., Игоревич, К. К., Геннадиевна, Я. М., & Lesovaya, E. A. (2022) · Siberian Journal of Oncology · doi:10.21294/1814-4861-2022-21-3-50-60 · Cited by 1 · see citing works

Long Non-Coding RNAs, Nuclear Receptors and Their Cross-Talks in Cancer—Implications and Perspectives

Tiwari, P., & Tripathi, L. P. (2024) · Cancers · doi:10.3390/cancers16162920 · Cited by 1 · see citing works

Characterising mechanisms of aberrant androgen receptor signalling in advanced prostate cancer

Guo, W., Robson, C. N., & Gaughan, L. (2016) · Endocrine Abstracts · doi:10.1530/endoabs.42.p23

HSP90-Based Heterocomplex as Essential Regulator for Cancer Disease

Galigniana, M. D. (2019) · Heat shock proteins · doi:10.1007/978-3-030-23158-3_2

Autophagy activation in breast cancer cells in vitro after the treatment with PI3K/AKT/mTOR inhibitors

Grigoreva, D. D., Михайловна, Ж. Е., Lylova, E. S., Enikeev, A. D., Игоревич, К. К., Belitsky, G. A., Геннадиевна, Я. М., & Lesovaya, E. A. (2022) · Advances in molecular oncology · doi:10.17650/2313-805x-2022-9-4-61-70

Biomarkers of psychological stress are associated with increased susceptibility to the development of breast and prostate cancer in BRCA1/2 mutation carriers

Flaherty, R. L., Falcinelli, M., Hesketh, A. R., Patel, B. A., Bancroft, E. K., Page, E. C., Eeles, R. A., & Flint, M. S. (2025) · British Journal of Cancer · doi:10.1038/s41416-025-03085-3 · Cited by 1 · see citing works

Expression of Glucocorticoid Receptor Beta in Bladder Cancer and Its Clinicopathological Significance: A Novel Diagnostic Marker to Predict Progression and Recurrence of Cancer

Kukimoto, T., Nakamura, Y., Hata, S., Shimada, H., Ogata, T., Kato, M., Saito, H., Kusumoto, H., Oikawa, M., Morozumi, K., et al. (2025) · International Journal of Urology · doi:10.1111/iju.70254

The Path to Cancer Cure

Paul, D. (2025) · Springer eBooks · doi:10.1007/978-3-032-08808-6_12 · Cited by 2 · see citing works

New insights on anticancer glucocorticoid receptor modulators: a patent review (2020-present)

Franzin, M., Lucafò, M., Curci, D., Decorti, G., & Stocco, G. (2026) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2026.2689602

Is the glucocorticoid receptor a key player in prostate cancer?: A literature review

Sakellakis, M., & Flores, L. J. (2022) · Medicine · doi:10.1097/md.0000000000029716 · Cited by 17 · see citing works

The glucocorticoid receptor interferes with progesterone receptor-dependent genomic regulation in breast cancer cells

Ogara, M. F., Rodríguez‐Seguí, S. A., Marini, M., Nacht, A. S., Stortz, M., Levi, V., Presman, D. M., Vicent, G. P., & Pecci, A. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz857 · Cited by 45 · see citing works

Abstract ES9-3: Androgen, progesterone and glucocorticoid receptors: Drivers of breast tumor progression or reprogramming of steroid receptors during breast tumor progression

Conzen, S. (2018) · Cancer Research · doi:10.1158/1538-7445.sabcs17-es9-3

OR22-04 The Oncogenic Action Of Glucocorticoid Receptor In Prostate Cancer

Paakinaho, V. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad114.1765

Genome-wide crosstalk between steroid receptors in breast and prostate cancers

Paakinaho, V., & Palvimo, J. J. (2021) · Endocrine Related Cancer · doi:10.1530/erc-21-0038 · Cited by 55 · see citing works